CCR8 regulates contact hypersensitivity by restricting cutaneous dendritic cell migration to the draining lymph nodes
- PMID: 25344933
- DOI: 10.1093/intimm/dxu098
CCR8 regulates contact hypersensitivity by restricting cutaneous dendritic cell migration to the draining lymph nodes
Abstract
Allergic contact dermatitis (ACD) is a typical occupational disease in industrialized countries. Although various cytokines and chemokines are suggested to be involved in the pathogenesis of ACD, the roles of these molecules remain to be elucidated. CC chemokine receptor 8 (CCR8) is one such molecule, of which expression is up-regulated in inflammatory sites of ACD patients. In this study, we found that Ccr8(-/-) mice developed severer contact hypersensitivity (CHS) responses to 2,4-dinitrofluorobenzene, a murine model of ACD, compared with wild-type mice. T cells from Ccr8(-/-) mice showed enhanced proliferative recall responses and Th1 and Th17 cell populations were expanded in these mice. However, CHS responses were similar between SCID mice adoptively transferred with Ccr8(-/-) and wild-type T cells, suggesting that CCR8 in T cells is not responsible for the exacerbation of CHS. Notably, skin-resident dendritic cells (DCs), such as Langerhans cells and dermal DCs, and inflammatory DCs were highly accumulated in lymph nodes (LNs) of Ccr8(-/-) mice after sensitization. Consistent with this, Ccr8(-/-) antigen-presenting cells readily migrated from the skin to the draining LNs after sensitization. These observations suggest that CCR8 negatively regulates migration of cutaneous DCs from the skin to the draining LNs in CHS by keeping these cells in the skin.
Keywords: CCR8; Langerhans cells; contact hypersensitivity; dermal dendritic cells; migration.
© The Japanese Society for Immunology. 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.J Immunol. 2009 Mar 1;182(5):2708-16. doi: 10.4049/jimmunol.0803704. J Immunol. 2009. PMID: 19234165
-
Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization.J Immunol. 2000 May 15;164(10):5207-14. doi: 10.4049/jimmunol.164.10.5207. J Immunol. 2000. PMID: 10799880
-
IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity.Int Immunol. 2001 Dec;13(12):1471-8. doi: 10.1093/intimm/13.12.1471. Int Immunol. 2001. PMID: 11717188
-
Immunological mechanisms of contact hypersensitivity in mice.APMIS. 2012 Jan;120(1):1-27. doi: 10.1111/j.1600-0463.2011.02832.x. Epub 2011 Nov 11. APMIS. 2012. PMID: 22151305 Review.
-
Novel concept of iSALT (inducible skin-associated lymphoid tissue) in the elicitation of allergic contact dermatitis.Proc Jpn Acad Ser B Phys Biol Sci. 2016;92(1):20-8. doi: 10.2183/pjab.92.20. Proc Jpn Acad Ser B Phys Biol Sci. 2016. PMID: 26755397 Free PMC article. Review.
Cited by
-
The Chemokine Receptor CCR8 Promotes the Migration of Dendritic Cells into the Lymph Node Parenchyma to Initiate the Allergic Immune Response.Immunity. 2018 Sep 18;49(3):449-463.e6. doi: 10.1016/j.immuni.2018.07.012. Epub 2018 Aug 28. Immunity. 2018. PMID: 30170811 Free PMC article.
-
Horizontal gene transfer events reshape the global landscape of arm race between viruses and homo sapiens.Sci Rep. 2016 Jun 7;6:26934. doi: 10.1038/srep26934. Sci Rep. 2016. PMID: 27270140 Free PMC article.
-
Chemokine Receptor-Targeted Therapies: Special Case for CCR8.Cancers (Basel). 2022 Jan 20;14(3):511. doi: 10.3390/cancers14030511. Cancers (Basel). 2022. PMID: 35158783 Free PMC article. Review.
-
Anti-inflammatory potential of Capparis spinosa L. in vivo in mice through inhibition of cell infiltration and cytokine gene expression.BMC Complement Altern Med. 2017 Jan 31;17(1):81. doi: 10.1186/s12906-017-1569-7. BMC Complement Altern Med. 2017. PMID: 28143472 Free PMC article.
-
Type 2 immunity in allergic diseases.Cell Mol Immunol. 2025 Mar;22(3):211-242. doi: 10.1038/s41423-025-01261-2. Epub 2025 Feb 17. Cell Mol Immunol. 2025. PMID: 39962262 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases